packageRivaroxaban

rivaroxaban

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Rivaroxaban is an anticoagulant that directly inhibits factor Xa and is used to prevent and treat blood clots, including venous thromboembolism, pulmonary embolism, and stroke prevention in atrial fibrillation. It is widely used and authorised in the European Union, with several approved products on the market.

Summary written by glm-5.3-flash from Wikidata Q420262 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:rivaroxaban
ATC codes:B01AF01
DrugBank:DB06228
PubChem CID:9875401
ChEBI:68579
Wikidata:Q420262
formula:C19H18ClN3O5S
molar mass:435.879 g/mol (PubChem CID 9875401)
logP:2.5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown